Gainesville, FLNCT06846281Now EnrollingIRB Ready

Relapsing Multiple Sclerosis Clinical Trial in Gainesville, FL

Access cutting-edge relapsing multiple sclerosis treatment through this clinical trial at a research site in Gainesville. Study-provided care at no cost to qualified participants.

Sponsored by Novartis Pharmaceuticals

Quick Self-Assessment

See if you qualify for this Gainesville location

Preparing your pre-screening questions…

Expert Care in Gainesville

Access relapsing multiple sclerosis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related relapsing multiple sclerosis treatment provided free

Apply for This Gainesville Location

Check if you qualify for this relapsing multiple sclerosis clinical trial in Gainesville, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Gainesville

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Gainesville site if eligible
  4. 4Begin participation

About This Relapsing Multiple Sclerosis Study in Gainesville

The purpose of this Phase 3b study is to assess the efficacy, safety and tolerability of remibrutinib after switching from ocrelizumab and compared to continuous ocrelizumab treatment, in patients living with relapsing multiple sclerosis (plwRMS).

Sponsor: Novartis Pharmaceuticals

Who Can Participate

Inclusion Criteria

Male or female aged 40 to 70 years (inclusive)
Diagnosis of RMS according to the 2017 McDonald diagnostic criteria
Treated with ocrelizumab according to routine clinical practice and at standard dose
Neurologically stable within 30 days
Suitable to be switched to remibrutinib based on physician judgement or patient preference Key

Exclusion Criteria

Diagnosis of primary progressive multiple sclerosis (PPMS) according to the revised 2017 McDonald criteria
History of clinically significant Central Nervous System disease or neurological disorders
History of confirmed Progressive Multifocal Leukoencephalopathy or neurological symptoms consistent
Active clinically significant systemic bacterial, viral, parasitic or fungal infections
Active, chronic disease of the immune system other than MS
Severe cardiac disease or significant findings on the ECG
Participant who is unable to undergo MRI scans
History of life-threatening infusion or injection reaction related to ocrelizumab Other inclusion and exclusion criteria may apply

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Gainesville?

Yes, this clinical trial (NCT06846281) has an active research site in Gainesville, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Relapsing Multiple Sclerosis Treatment Options in Gainesville, FL

If you're searching for relapsing multiple sclerosis treatment options in Gainesville, FL, this clinical trial (NCT06846281) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Gainesville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced relapsing multiple sclerosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all relapsing multiple sclerosis clinical trials near you to find additional studies recruiting in your area.

More Multiple Sclerosis Trials in Gainesville, FL

See all multiple sclerosis clinical trials recruiting in Gainesville — not just this study.

Browse Multiple Sclerosis Trials in Gainesville

Ready to Join in Gainesville?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Gainesville, FL